Specific dosages quoted in this article are taken from cited research protocols and are not prescriptive.
TB-500 and BPC-157 are typically dosed in micrograms (mcg) via subcutaneous or intramuscular injection, with common protocols ranging from 250 mcg to 1 mg daily or every other day. For BPC-157, a standard dosage chart lists 250-500 mcg once or twice daily for 2-4 weeks, then a maintenance phase. For TB-500, the chart usually starts at 2.5 mg twice weekly for 4 weeks, followed by 2.5 mg weekly or biweekly. These figures reflect community-reported protocols, not FDA-approved guidelines, since neither peptide is approved for human use in Canada. In Montreal, sourcing research-grade peptides requires care because Health Canada restricts their sale for human consumption.
What is the standard BPC-157 dosage chart?
BPC-157 is most often charted at 250-500 mcg per day, split into one or two injections. A common schedule is 250 mcg in the morning and 250 mcg in the evening for the first two weeks, then 250 mcg once daily for another two weeks. Some protocols extend to 500 mcg twice daily for acute injuries, but that is the upper end of community reports. The peptide is injected subcutaneously near the injury site, though systemic effects are also reported. Cycle length rarely exceeds 8 weeks before a break of equal length.
The rationale for twice-daily dosing comes from BPC-157's short half-life in the body. Because it degrades quickly, splitting the dose maintains steadier levels. A mistake many first-time researchers make is injecting intramuscularly when subcutaneous works just as well and is easier to manage. Another common error is expecting results in days; most users report noticeable changes after two to three weeks of consistent dosing.
What is the standard TB-500 dosage chart?
TB-500, a synthetic fragment of thymosin beta-4, is charted differently because its effects last longer. The typical starting protocol is 2.5 mg injected twice per week for four weeks. After that loading phase, the chart drops to 2.5 mg once per week or once every two weeks for maintenance. Total weekly dose in the loading phase is 5 mg, which is higher than BPC-157 because TB-500 is a larger molecule with a longer half-life.
Injections are usually subcutaneous or intramuscular, and the site matters less than with BPC-157 because TB-500 travels systemically. Users often inject into the abdomen or thigh. A key trade-off: TB-500 costs more per milligram than BPC-157, but the less frequent dosing schedule can make it more convenient. The loading phase is where most of the benefit appears; extending it beyond six weeks without a break is not supported by community data.
Can you stack TB-500 and BPC-157 together?
Yes, stacking is common and the dosage charts can be combined without changing either peptide's individual schedule. A typical stack uses BPC-157 at 250-500 mcg daily and TB-500 at 2.5 mg twice weekly for the first four weeks, then TB-500 drops to once weekly. The two peptides work through different mechanisms: BPC-157 promotes angiogenesis and accelerates soft tissue repair, while TB-500 modulates actin and supports cell migration. Together they are often used for tendon, ligament, and muscle recovery.
The main practical issue is injection volume and frequency. You will be injecting BPC-157 once or twice daily plus TB-500 twice weekly, which means multiple syringes and careful scheduling. Some users combine both peptides into one syringe if they are reconstituted separately and drawn in the right order, but this is not recommended unless you are experienced. A common mistake is drawing from the TB-500 vial first, which can contaminate the BPC-157 vial with residual TB-500.
What do I need to know about buying TB-500 and BPC-157 in Montreal?
In Montreal, TB-500 and BPC-157 are not sold in pharmacies for human use. They are available as research chemicals from online vendors, and shipping within Canada usually takes 2-5 business days. Health Canada has not approved either peptide for therapeutic use, so any purchase is for laboratory research only. Montreal Peptides is one local source that ships from within Canada, which avoids customs delays that can occur with international orders.
When buying, look for vendors that provide third-party purity testing, typically HPLC reports showing 98% or higher purity. Avoid any seller that markets the peptides for human injection or makes medical claims. Reconstitution requires bacteriostatic water, and you will need to calculate your own dosage from the vial size. A 5 mg vial of BPC-157 reconstituted with 2 mL of water gives 250 mcg per 0.1 mL, which is a standard starting point.
What are the risks and side effects of these dosage charts?
Published human data on TB-500 and BPC-157 is scarce; most research is in animal models. Reported side effects from community use include injection site reactions, transient fatigue, and headache. BPC-157 has an excellent safety profile in rodent studies even at high doses, but that does not guarantee human safety. TB-500 carries a theoretical concern about promoting angiogenesis in existing tumors, so anyone with a cancer history should avoid it.
The biggest practical risk is dosing error. Reconstituting a 5 mg vial and miscalculating the volume can lead to injecting ten times the intended dose. Always double-check your math and use insulin syringes with clear markings. Another risk is buying from an unverified vendor and receiving a vial that is underdosed or contaminated. In Montreal, the lack of local regulation means you are responsible for verifying quality.
FAQ
How long does a vial of BPC-157 last at the standard dosage?
A 5 mg vial of BPC-157 lasts 10-20 days at 250-500 mcg daily. At 250 mcg once daily, it lasts 20 days. At 250 mcg twice daily, it lasts 10 days. Most users buy multiple vials for a full 4-week cycle.
Should I inject TB-500 and BPC-157 at the same time of day?
No specific timing is required. BPC-157 is often split morning and evening, while TB-500 can be injected any time on its scheduled days. Consistency matters more than clock time. Avoid injecting both into the exact same spot on the same day to reduce irritation.
Do I need to refrigerate reconstituted peptides?
Yes. Once reconstituted with bacteriostatic water, both TB-500 and BPC-157 should be refrigerated at 2-8 degrees Celsius. Unreconstituted vials can be stored at room temperature away from light, but refrigeration extends shelf life. Never freeze reconstituted peptides.
Can women use the same dosage chart as men?
Community reports do not show a consistent sex-based dose adjustment for either peptide. Most women use the same 250-500 mcg BPC-157 and 2.5 mg TB-500 protocols. Body weight is not a major factor in these charts because the peptides act locally and systemically rather than by volume of distribution.